Skip to main content
CARCLO PLC logo

CARCLO PLC — Investor Relations & Filings

Ticker · CAR ISIN · GB0001751915 LEI · 21380078MEM399JPI956 IL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2018-07-23 Regulatory Filings
Country GB United Kingdom
Listing IL CAR

About CARCLO PLC

http://www.carclo-plc.com/

Carclo PLC is a global precision engineering group that designs, industrializes, and manufactures high-reliability solutions and complex components. The company specializes in fine-tolerance, injection-molded plastic parts and multi-component assemblies. Its core competencies encompass the entire production lifecycle, from initial design, engineering, and mold creation to advanced manufacturing processes like precision injection molding and automated assembly. Carclo provides comprehensive supply chain solutions, serving demanding, precision-focused markets including Life Sciences, Aerospace, Optics, and other advanced technology sectors. Key product areas include components for in-vitro diagnostics, drug delivery systems, and advanced optical systems.

Recent filings

Filing Released Lang Actions
Form 8.3 - Carclo plc
Regulatory Filings Classification · 98% confidence The document is explicitly labeled as 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates to insider transactions or significant changes in share ownership during a takeover scenario. While it involves director/insider activity (similar to DIRS), the specific context of a Takeover Code disclosure (Form 8.3) dealing with interests in securities during an offer is a specialized regulatory filing. Since there is no specific code for 'Takeover Disclosure', and it is a mandatory regulatory filing disseminated via RNS, it best fits the general 'Regulatory Filings' category (RNS) or potentially 'Director's Dealing' (DIRS). However, DIRS is usually for routine insider trades (like Form 4 in the US), whereas this is tied to a specific M&A/Takeover event disclosure requirement (Form 8.3). Given the explicit mention of RNS and the nature of mandatory disclosure to a Regulatory Information Service, RNS is the most appropriate general regulatory bucket, although it is highly specific. If we strictly follow the definitions, it is a regulatory announcement, not a report itself. It is not a Director's Dealing (DIRS) as DIRS is defined as 'Report of personal share transactions by company directors and executives (insider trades)', and this is a specific Takeover Code disclosure. Therefore, RNS (General regulatory announcements and fallback category) is the best fit.
2018-07-23 English
Form 8.3 - Carclo plc - Ordinary shares
Regulatory Filings Classification · 95% confidence The document is explicitly titled "FORM 8.3 - Carclo plc - Ordinary shares" and references "Rule 8.3 of the Takeover Code (the “Code”)". This form is a Public Opening Position Disclosure/Dealing Disclosure by a person holding 1% or more interests in relevant securities during a takeover situation. This type of filing relates to insider transactions or significant ownership changes during a takeover bid, which falls under the scope of Director's Dealing (DIRS) or potentially a specific regulatory filing. Since the definitions provided do not have a specific code for 'Takeover Code Disclosure Form 8.3', I must evaluate the closest fit. Director's Dealing (DIRS) covers personal share transactions by directors/executives. While this is an institutional manager (Dimensional Fund Advisors Ltd.), the nature of the disclosure—reporting interests and dealings in securities related to an offeror/offeree—is fundamentally about insider/significant shareholder activity during a corporate action. However, the most precise category for disclosures related to insider transactions, even if not strictly directors, is often grouped with DIRS or falls under general regulatory filings. Given the specific context of a takeover code disclosure (Rule 8.3), which mandates reporting of interests and dealings by parties involved in an offer, it is a highly specific regulatory disclosure. Since DIRS is defined as 'Report of personal share transactions by company directors and executives (insider trades)', and this is a mandatory disclosure under the Takeover Code, it is a form of insider/significant shareholder reporting. If DIRS is too narrow (as it specifies directors/executives), the next best fit is the general regulatory fallback (RNS). However, Form 8.3 is a very specific type of insider transaction disclosure related to M&A activity. Given the options, DIRS is the closest thematic fit for reporting significant security interests/dealings by an involved party, although RNS is the fallback. Considering the document is a mandatory disclosure about security holdings/dealings during a takeover, and there is no specific 'Takeover Disclosure' code, I will classify it as Director's Dealing (DIRS) as it concerns insider/significant shareholder transaction reporting, or RNS as a specific regulatory filing. Since the document explicitly mentions dealings and interests in securities during an offer, and DIRS covers insider trades, I will lean towards DIRS as the most specific functional match, acknowledging it's an institutional disclosure rather than strictly a director's personal trade. Upon re-evaluation, Form 8.3 is a mandatory disclosure under the Takeover Code, distinct from routine insider trading reports (like Form 4 in the US) or standard director dealings. It is a specific regulatory filing related to an ongoing M&A event. Since RNS is the general regulatory fallback, and this is a highly specific regulatory document not covered by other specific financial reports (10-K, IR, ER, etc.), RNS is the most appropriate classification.
2018-07-23 English
Form 8.5 (EPT/RI) Consort Medical Plc
Regulatory Filings Classification · 98% confidence The document is a 'Form 8.5 (EPT/RI)' which is a standard regulatory disclosure form used in the UK under the Takeover Code for exempt principal traders to report dealings in securities related to an offer. While it relates to M&A activity (Takeover Code), it is specifically a regulatory disclosure of trading activity rather than a merger announcement or takeover bid document itself. Given the specific nature of these disclosures under the Takeover Code, 'RNS' (Regulatory Filings) is the most appropriate classification for this type of regulatory announcement.
2018-07-20 English
Form 8.5 (EPT/RI) - Carclo Plc
Regulatory Filings Classification · 98% confidence The document is explicitly identified as a 'FORM 8.5 (EPT/RI)' and references 'Rule 8.5 of the Takeover Code (the "Code")'. It details 'PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER' concerning securities of 'Carclo Plc' and 'Consort Medical Plc', which strongly indicates activity related to a takeover or merger situation. The content details specific purchases and sales of ordinary shares by a principal trader. This type of disclosure, related to insider/principal trading during a takeover process, is a specific regulatory filing. While it involves dealing (POS) and relates to a takeover (TAR), the specific form (8.5) and context point towards a specialized regulatory disclosure. Given the options, 'Director's Dealing' (DIRS) covers insider transactions, but this is a specific 'Principal Trader' disclosure under Takeover Code rules. Since it is a formal regulatory filing related to a takeover/dealing, and there isn't a perfect fit for 'Takeover Code Disclosure', we must evaluate the closest categories. Director's Dealing (DIRS) is for directors/executives. This is a principal trader. The most appropriate general category for specific, non-standard regulatory disclosures that aren't earnings or annual reports is often 'Regulatory Filings' (RNS) or potentially 'Transaction in Own Shares' (POS) if it were the company itself, or 'M&A Activity' (TAR) due to the Takeover Code context. However, Form 8.5 is a specific disclosure required under the Takeover Code regarding dealings by exempt principal traders during an offer. This is a highly specific regulatory filing. Given the options, and recognizing this is a mandatory disclosure related to a potential takeover (as indicated by the parties involved and the Code reference), 'M&A Activity' (TAR) is plausible, but 'Regulatory Filings' (RNS) serves as the best general category for mandatory, specific regulatory forms that don't fit the core financial reports (10-K, IR, ER). Since the document is a formal, structured regulatory disclosure (RNS Number is present), RNS is the most robust classification for this type of mandatory filing that isn't a core financial statement or a simple announcement of a report.
2018-07-20 English
Form 8.3 - Carclo plc - Ordinary shares
Major Shareholding Notification Classification · 96% confidence The document is explicitly titled 'FORM 8.3 - Carclo plc - Ordinary shares' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interest in relevant securities during a takeover situation. This type of disclosure relates to insider/significant shareholder activity during a takeover bid. Among the provided categories, 'Director's Dealing (DIRS)' covers personal share transactions by executives, and while this is a dealing disclosure, the context is specifically related to a takeover bid under the Takeover Code, which often involves significant shareholding changes or actions related to the offer. However, the most specific category that captures significant shareholder activity/insider trading related to corporate actions, especially those involving takeovers, is often grouped with insider transactions. Given the options, 'Director's Dealing (DIRS)' is the closest fit for reporting personal/managerial interests and dealings, even though the discloser is an investment manager (Dimensional Fund Advisors Ltd.) rather than a director, as the core function is reporting interests/dealings in securities relevant to a corporate action (the takeover). If a more specific 'Takeover Disclosure' category existed, it would be preferred. Since it involves reporting dealings/interests by a major holder during a potential takeover, and DIRS covers executive/director dealings, I will check other options. 'Major Shareholding Notification (MRQ)' is for crossing ownership thresholds, which is related but less specific than a takeover disclosure. 'Director's Dealing (DIRS)' is the best fit among the provided codes for reporting significant security interests and transactions by involved parties during a corporate event like a takeover, as it covers insider/significant holder transactions.
2018-07-20 English
Board Changes
Board/Management Information Classification · 99% confidence The document is a short announcement (2684 characters) identified by an 'RNS Number' and dated July 20, 2018. The content explicitly details changes in the company's Board of Directors, including retirements and new appointments, and includes quotes from the new Chairman. This directly matches the definition for Board/Management Information (MANG). It is not a full report, an earnings release, or a proxy statement.
2018-07-20 English

Browse filings by year

37 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.